RSS服務
網站導覽
  乳房醫學中心
字體縮放: 字體小 字體中 字體大
醫師陣容(乳癌篩檢)
醫師陣容(乳癌篩檢)內容
職  稱

林惠鈺醫師

現 任

•乳房醫學中心主任、一般外科主治醫師
•輔仁大學醫學系專任助理教授

學 歷

台北醫學大學臨床醫學博士

經 歷

•台北榮總一般外科及乳房醫學中心醫師
•彰基乳房醫學中心次專科臨床研究醫師
•耕莘醫院外科部主治醫師、IRCAD微創手術中心訓練醫師
•台灣乳房醫學會會員、台灣乳房外科專科醫師、台灣外科專科醫師、台灣消化外科專科醫師

專長主治項目

•乳房及乳癌手術: 改良式全乳切除術、乳癌全乳切除立即乳房重建手術、保乳式乳癌切除手術、乳房腫瘤整形式切除手術(Oncoplastic surgery)、乳癌術中放射線治療(IORT), 乳癌藥物治療 :化學治療、標靶治療、抗賀爾蒙治療、免疫治療
•乳房美型微創手術、內視鏡乳房切除微創手術
•乳房疾病之診斷與治療、乳房超音波檢查及超音波下引導切片、細針定位切片及麥馬通/安可切片技術(Mammotone / En-cor)、人工血管置放術、外傷處置等

得獎

台灣乳癌防治基金會 2020優秀論文佳作
台灣乳房醫學會 2021台北國際乳癌研討會優秀論文第二名

著作

1. Chia-Hao Kuei, Hui-Yu Lin, Min-Hsuan Lin, Hsun-Hua Lee, Che-Hsuan Lin,
Wei-Jiunn Lee, Yen-Lin Chen, Long-Sheng Lu, Jing-Quan Zheng, Ruei-Chen
Hung, Hui-Wen Chiu, Kuan-Chou Chen, Yuan-FengLin (2020, Dec). DNA
polymerase theta repression enhances the docetaxel responsiveness in metastatic
castration-resistant prostate cancer. Biochimica et Biophysica Acta (BBA) -
Molecular Basis of Disease, Volume 1866, Issue 12, 1 December 2020, 165954.

2. Hui-Yu Lin, Chia-Hao Kuei, Hsun-Hua Lee, Che-Hsuan Lin, Jing-Quan Zheng,
Hui-Wen Chiu,Chi-Long Chen, and Yuan-Feng Lin (2020, Jul). The
Gαh/phospholipase C-δ1 interaction promotes autophagosome degradation by
activating the Akt/mTORC1 pathway in metastatic triple-negative breast cancer.
Gαh/磷脂酶 C-δ1 相互作用激活 Akt/mTORC1 通路促進自噬體降解在轉移性三陰性乳癌中。
Aging-US, Aging (Albany NY). 2020 Jul 15; 12(13): 13023–13037.

3. Hui-Yu Lin, Chia-Hao Kuei, Hsun-Hua Lee, Che-Hsuan Lin, Yen-Lin Chen, ChiLong Chen & Yuan-Feng Lin (2020, Jul). TNFSF13 upregulation confers
chemotherapeutic resistance via triggering autophagy initiation in triple-negative
breast cancer. 上調TNFSF13賦予三陰性乳癌患者通過觸發自噬引發化療耐藥性Journal of molecular Medicine, Journal of Molecular Medicine
volume 98, pages1255–1267(2020).

4. Chia-Hao Kuei 1 2, Hui-Yu Lin 1 3, Hsun-Hua Lee 1 4 5 6, Che-Hsuan Lin 7 8,
Jing-Quan Zheng 1 9, Kuan-Chou Chen 1 10 11, Yuan-Feng Lin 1 12 (2020,
May). IMPA2 Downregulation Enhances mTORC1 Activity and Restrains
Autophagy Initiation in Metastatic Clear Cell Renal Cell Carcinoma. Journal of
clinical medicine, J Clin Med . 2020 Mar 30;9(4):956.

5. Hsun-Hua Lee, Che-Hsuan Lin, Hui-Yu Lin, Chia-Hao Kuei, Jing-Quan Zheng,
Yuan-Hung Wang, Long-Sheng Lu, Fei-Peng Lee, Chaur-Jong Hu, Dean Wu,
and Yuan-Feng Lin (2019, Dec). Histone 2A Family Member J Drives
Mesenchymal Transition and Temozolomide Resistance in Glioblastoma
Multiforme. cancers, 2020, 12(1), 98;.

6. Che-Hsuan Lin, Hsun-Hua Lee, Chia-Hao Kuei, Hui-Yu Lin, Long-Sheng Lu,
Fei-Peng Lee, Jungshan Chang,Jia-Yi Wang,* Kai-Cheng Hsu,* and Yuan-Feng
Lin (2019, Sep). Nicotinic Acetylcholine Receptor Subunit Alpha-5 Promotes
Radioresistance via Recruiting E2F Activity in Oral Squamous Cell Carcinoma.
Journal of clinical medicine, 2019 Sep; 8(9): 1454.

7. Hui-Wen Chiu, Jeng-Shou Chang, Hui-Yu Lin, Hsun-Hua Lee, Chia-Hao Kuei,
Che-Hsuan Lin, Huei-Mei Huang *, Yuan-Feng Lin (2018, Oct). FBXL7
Upregulation Predicts a Poor Prognosis and Associates with a Possible
Mechanism for Paclitaxel Resistance in Ovarian Cancer. Journal of clinical
medicine, 7(10), 330.

8. Lin YF, Tseng IJ, Kuo CJ, Lin HY, Chiu IJ, Chiu HW (2018, Apr). High-level
expression of ARID1A predicts a favourable outcome in triple-negative breast
cancer patients receiving paclitaxel-based chemotherapy. 高水平ARID1A 的表達預測接受紫杉醇的化療的三陰性乳癌患者的良好結果。 Journal of Cellular and
Molecular Medicine, 22(4):2458-2468.
9. Hung-Wen Lai, Ren-Hung Huang, Yu-Ting Wu, Chih-Jung Chen, Shou-Tung
Chen,, Ying-Jen Lin, Dar-Ren Chen, Chih-Wei Lee, Hwa-Koon Wu, Hui-Yu Lin,
Shou-Jen Kuo (2018, Jan). Clinicopathologic factors related to surgical margin
involvement, reoperation, and residual cancer in primary operable breast cancer
– An analysis of 2050 patients. – 對 2050 名之原發可手術乳癌患者的分析手術切緣、再次手術和殘留癌相關的臨床病理因素
。European Journal of Surgical Oncology, Volume
44, Issue 11, Pages 1725–1735 .

10. Chiu HW, Lin HY, Tseng IJ, Lin YF (2017, Dec). OTUD7B upregulation
predicts a poor response to paclitaxel in patients with triple-negative breast
cancer. OTUD7B 上調可預測三陰性乳癌患者對紫杉醇的反應不佳。Oncotarget , 9(1):553-565.

11. Hung-Wen Lai, MD,PhD; Hui-Yu Lin, MD; Shu-Ling Chen, MS; Shou-Tung
Chen, MD; Dar-Ren Chen, MD; Shou-Jen Kuo, MD (2017, Jan). Endoscopyassisted surgery for the management of benign breast tumors: Technique, learning curve, and patient-reported outcome from preliminary 323 procedures. 用於治療良性乳腺腫瘤的內視鏡輔助手術:技術,學習曲線,以及來自初步 323 程序的患者報告結果。
World Journal of Surgical Oncology, World Journal of Surgical Oncology2017,
15:19. 林惠鈺為共同第一作者.

12. Hui-Yu Lin, Shao-Jiun Chou1*, Tze-Kai Chen (2015, Sep). A non-hematuria
urachal adenocarcinoma in a form of an infected umbilical mass: Case report .
International Journal of Advances In Case Reports, Volume 2, Issue 9, 2015;
1197-1199.

13. 林惠鈺 、 廖俊厚 、 周有偉 (2016年06月)。Lung Adenocarcinoma
Metastatic to an Indirect Inguinal Hernia Sac: A Case Report and Literature
Review。Fu-Jen Journal of Medicine,2016 Vol.14 No.2; 077-082。

網路掛號 林惠鈺醫師網路掛號連結
回瀏覽頁
 
人才招募  |  資安暨隱私權政策  |  電子病歷  |  醫療資訊公開  |  問卷調查  |  熱門議題投票  |  線上藝廊  |  電子報  |  線上報名  |  院長信箱  |  網站導覽  | 
 
天主教耕莘醫療財團法人耕莘醫院
電話:耕莘醫院(02)22193391 / 安康院區(02)22123066 / 預約掛號:(02)22195028 
耕莘醫院地址:23148新北市新店區中正路362號 / 安康院區地址:23155新北市新店區車子路15號 / Email:service@cth.org.tw
耕莘醫院:民眾意見服務 轉66101.66103 / 轉診中心 轉15117 / 健康衛教諮詢 轉67156 / 安康院區:民眾意見服務 轉56136 / 免費醫療諮詢 0800723885